CXCR2 and neoplasm: In addition, CXCR2-deficient mice display the characteristics of decreased Gr1+ tumor-associated granulocytes, F4/80+ tumor-associated macrophages, and CD11b+Gr1+ MDSCs, as well as delayed tumor progression19.